HOSPITALIZATIONS AMONG PATIENTS WITH BOTH COLORECTAL CANCER AND TYPE II DIABETES MELLITUS TREATED WITH METFORMIN VS. SULFONYLUREAS: A SEER-MEDICARE ANALYSIS

被引：0
|
作者：
Rane, A. [1 ]
Reddy, S. [2 ]
Kaliki, S. [2 ]
Kaler, N. [2 ]
Dungrani, R. K. [2 ]
Patel, N. [2 ]
Murimi, I. B. [2 ]
机构：
[1] Agios Pharmaceut, Cambridge, MA USA
[2] MCPHS Univ, Boston, MA USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD116
引用
收藏
页码：S383 / S383
页数：1
相关论文
共 50 条
  • [1] TREATMENT PATTERNS AMONG ELDERLY METASTATIC COLORECTAL CANCER PATIENTS - A SEER-MEDICARE ANALYSIS
    Parikh, R. C.
    Du, X. L.
    Morgan, R. O.
    Lairson, D. R.
    VALUE IN HEALTH, 2015, 18 (03) : A1221 - A1221
  • [2] A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer patients
    Garcia, C.
    Yao, A.
    Camacho, F.
    Balkrishnan, R.
    Cantrell, L. A.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 146 - 147
  • [3] Impacts of Metformin & Diabetes and Statins & Hyperlipidemia in Head and Neck Cancer: An Analysis of the SEER-Medicare Dataset
    Stokes, W. A.
    Eguchi, M.
    Amini, A.
    Ding, D.
    Lanning, R. M.
    McDermott, J.
    Raben, D.
    Bradley, C. J.
    Karam, S. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1324 - 1324
  • [4] The Use of Metformin and Colorectal Cancer Incidence in Patients with Type II Diabetes Mellitus
    Smiechowski, Brielan
    Azoulay, Laurent
    Yin, Hui
    Pollak, Michael N.
    Suissa, Samy
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (10) : 1877 - 1883
  • [5] COMPARING CARDIAC SAFETY PROFILE OF METFORMIN AND SULFONYLUREAS IN COLORECTAL CANCER (CRC) PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM): SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS (SEER) MEDICARE
    Allen, C.
    O'Mara, A.
    Zyfi, D.
    Krishnamurthi, J.
    Patel, N. M.
    Okoli, O. A.
    Murimi-Worstell, I. B.
    VALUE IN HEALTH, 2023, 26 (06) : S165 - S165
  • [6] Thromboembolic Events Among Older Ovarian Cancer Patients: A SEER-Medicare Analysis
    Shantakumar, Sumitra
    Frost, Alexandra C.
    Li, Li
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 410 - 410
  • [7] Cardiovascular Benefits of Acarbose vs Sulfonylureas in Patients With Type 2 Diabetes Treated With Metformin
    Hsu, Pai-Feng
    Sung, Shih-Hsien
    Cheng, Hao-Min
    Shin, Shyi-Jang
    Lin, Kun-Der
    Chong, Keong
    Yen, Fu-Shun
    Yu, Ben-Hui
    Huang, Chi-Ting
    Hsu, Chih-Cheng
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (10): : 3611 - 3619
  • [8] Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas
    Mamtani, Ronac
    Pfanzelter, Nick
    Haynes, Kevin
    Finkelman, Brian S.
    Wang, Xingmei
    Keefe, Stephen M.
    Haas, Naomi B.
    Vaughn, David J.
    Lewis, James D.
    DIABETES CARE, 2014, 37 (07) : 1910 - 1917
  • [9] Increased risks of type II diabetes among older Asian, Native Hawaiian, and Pacific Islander lung cancer survivors: a SEER-Medicare analysis
    Zhang, Yihang Freya
    Chang, Chun-Pin Esther
    Varghese Jr, Thomas K.
    Tao, Randa
    Hashibe, Mia
    JOURNAL OF CANCER SURVIVORSHIP, 2025,
  • [10] Patterns of care and survival trends in elderly metastatic colorectal cancer patients: A SEER-Medicare analysis
    Shankaran, V.
    Beck, S. J.
    Blough, D. K.
    Yim, Y.
    Yu, E.
    Ramsey, S. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
12345